Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • State News

    State News - Page 6

    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly

    Medical Dialogues Bureau20 Sept 2019 2:33 PM IST
    The Hyderabad Pharma City project has received an overwhelming response from the industry stakeholders, Telangana Minister for IT and Industries KT...
    BAN: Private Sectors wont be allowed to sell Detox Drug Buprenorphine in Punjab

    BAN: Private Sectors wont be allowed to sell Detox Drug Buprenorphine in Punjab

    Farhat Nasim10 Sept 2019 4:11 PM IST
    Apart from this, the Government intends to allow psychiatric clinics to dispense buprenorphine and naloxone. It is also in the process of framing...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    Unichem Labs successfully completes USFDA inspection of Pithampur facility

    Unichem Labs successfully completes USFDA inspection of Pithampur facility

    Medical Dialogues Bureau6 Sept 2019 9:45 AM IST
    "The United States Food and Drug Administration (USFDA) conducted an inspection at the Company's Pithampur, Active Pharmaceutical Ingredients (APIs)...
    Dr Abhinay named as new CEO of KIMS Hospitals

    Dr Abhinay named as new CEO of KIMS Hospitals

    Medical Dialogues Bureau31 Aug 2019 9:00 AM IST
    In his previous role as Vice-President, Dr Abhinay oversaw Business Development and Strategy for KIMS Hospitals, a statement said.Hyderabad:...
    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients

    Medical Dialogues Bureau29 Aug 2019 9:35 AM IST
    The U.S. Food and Drug Administration said on Wednesday it had identified 63 cases of worsening liver function in certain patients taking hepatitis C...
    Chemist license suspended for selling MTP pills sans prescription

    Chemist license suspended for selling MTP pills sans prescription

    Farhat Nasim28 Aug 2019 4:35 PM IST
    Indore: In a major crackdown, a chemist has been nabbed for selling abortion pills without medical prescription. The authority has suspended his...
    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    SastaSundar Healthbuddy, Mitsubishi Corp sign deal worth Rs 100 crore for affordable healthcare

    Medical Dialogues Bureau27 Aug 2019 9:45 AM IST
    Founder and CEO Ravi Kant Sharma added: "The partnership with Mitsubishi Corporation will help us to connect global resources with local care. It is a...
    GSK Belantamab Mafodotin shows to help blood cancer patients

    GSK Belantamab Mafodotin shows to help blood cancer patients

    Medical Dialogues Bureau26 Aug 2019 9:15 AM IST
    Two doses of Belantamab Mafodotin helped subdue the disease in adults who had received three prior treatments for multiple myeloma, a cancer of the...
    Much anticipated Medanta-Manipal deal comes to halt: Report

    Much anticipated Medanta-Manipal deal comes to halt: Report

    Farhat Nasim20 Aug 2019 1:49 PM IST
    Mumbai: The much anticipated Medanta-Manipal deal worth Rs 5800 crore has come to a halt. The deal failure is reportedly the result of valuation...
    Corruption: CDSCO Dty Drug controller arrested by CBI , suspended by Health Ministry

    Corruption: CDSCO Dty Drug controller arrested by CBI , suspended by Health Ministry

    Medical Dialogues Bureau19 Aug 2019 4:12 PM IST
    New Delhi The Union Health Ministry on Sunday said Deputy Drug Controller Dr Naresh Sharma, posted at the CDSCO headquarters, has been suspended...
    Cipla shareholders approve raising up to Rs 3,000 cr

    Cipla shareholders approve raising up to Rs 3,000 cr

    Medical Dialogues Bureau19 Aug 2019 3:34 PM IST
    New Delhi: Indian Drug major Cipla on Saturday said its shareholders have approved a proposal to raise up to Rs 3,000 crore through issuance of...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok